Back to search
Toxic Encephalopathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Toxic Encephalopathy trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Toxic Encephalopathy trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is an observational umbrella protocol evaluating toxicities after CAR-T therapy with ciltacabtagene autoleucel (cilta-cel) for RRMM, with a goal to identif…
This is a multi-part, open-label, non-randomized phase Ib/II clinical trial designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary ant…
The goal of this clinical trial is to learn if two non-pharmacological strategies can help reduce neurotoxicity caused by CAR-T cell therapy in adult patients w…
To learn about the relationship between changes in pupil size and reactivity and the start of neurological side effects in patients after receiving CAR-T cell t…
The goal of this clinical trial is to learn whether extracellular vesicles (EVs) in the blood can be used as biomarkers to predict chemotherapy-induced peripher…
This study aims to evaluate nerve excitability in participants with cisplatin-induced peripheral neuropathy (cis-PN) using threshold tracking nerve conduction s…
This study aims to characterize the relationship between plasma diquat concentrations and organ damage risk.
This study will analyze the effects of radiation given to children who have tumors of the central nervous system (CNS). Researchers want to learn more about cha…